Stem Cell Clinical Trials

Stem Cell Clinical Trials

By Michael Leshinski

The world of stem cell research has most recently made the news by entering the beginning stages of their first ever FDA approved clinical trials. The trials were supposed to begin by testing cells in humans with spinal cord injuries, but the FDA has decided to delay the testing without explanation. Although the duration of the delay is unknown, one can wonder what reasons supported its decision. It’s possible that safety precautions contributed to the delay, as the trials will set a precedent in the world of clinical studies. Or was the FDA pressured by conservative lobbyists who oppose the usage of stem cells? Ethical questions are raised all around in this instance. Is it ethical to harvest embryonic stem cells from fetal tissue if they can be used to treat disease and save lives? Is it ethical for lobbyists and PACs to persuade government agencies?

As a medical writer, I am here to provide an unbiased view and merely act as a relay point of information. Revealing my opinions about this subject would not only go against what I have learned, but also spawn a political debate which I am not interested in participating. I have adapted a policy just as the old saying says, ‘Never talk religion and politics’. Instead, I propose these questions to my fellow bio-ethicians. Think about what it takes to harvest stem cells. Then think about some of the possible diseases that can be fixed by its usage. It may or may not be easy to decide where you stand on the issue, but it is important that you think about it.